By Tokio X'press Vaccine, flu, bio, Medical science, Pharmaceutical
COVID-19: Yamasa supplies mRNA raw material: to Pfizer and Moderna
Kyoto University: Utilizing iPS cells for cancer immunotherapy: Proliferating killer T cells
Kyoto University: Reproduce intractable disease ALS with iPS cells: Therapeutic drug “Bosutinib”
South Korea: Nobel Prize Leading Candidate: Professor Ho-Wang Lee’s Career
COVID-19: Measured from 1 drop of blood in 30 minutes: Type and amount of antibody